|Bid||46.1700 x 1200|
|Ask||46.2500 x 1800|
|Day's Range||45.70 - 46.99|
|52 Week Range||18.93 - 59.25|
|Beta (3Y Monthly)||3.44|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Canopy Growth Corp (TSX:WEED)(NYSE:CGC) and other marijuana stocks could have a nasty surprise for cannabis investors this year.
IIPR, GTBIF, ITHUF: Key Updates from Last Week(Continued from Prior Part)Innovative Industrial Properties to offer exchangeable senior notes On February 15, 2019, Innovative Industrial Properties (IIPR) made an announcement that through its operating
HENDERSON, NV / ACCESSWIRE / February 19, 2019 / Cannabis stocks closed last week mostly higher, Canopy Growth and Aphria, two of the more well-known stocks in the industry each released positive press ...
DENVER, Feb. 19, 2019 /CNW/ -- As the cannabis sector consistently shows impressive growth, acquisitions within the market allow cannabis companies to develop greater vertical integration. - Cannabis companies are looking to acquire other organizations to strengthen specialist knowledge and skills. - Similar moves have led to impressive success in industries such as coffee production.
And what to look forward to based on the big Canadian marijuana growers' latest quarterly results.
Two of the biggest Canadian marijuana companies provided quarterly updates last week. Their results could be good news for other marijuana stocks, too.
Marijuana industry behemoths Canopy Growth Corp (TSX:WEED)(NYSE:CGC) and Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) reported solid earnings. Which stock is the better buy?
Critics have been calling for it for what seems like eons, but is the historic rally in cannabis stocks, including Canopy Growth Corp (TSX:WEED)(NYSE:CGC), finally coming to an end?
Cannabis stocks may be red hot, but "Bond King" Jeffery Gundlach issued caution to investors before being consumed by the "mania" in an exclusive interview with Yahoo Finance.
Cannabis companies like Curaleaf and Acreage can’t list their stocks in the U.S., or draw on U.S. bank lines. They also must cope with wide variations in state regulations. Don’t look for much progress from the federal government for at least a year.
A half-dozen companies are vying for leading roles in what bulls believe could be a $50 billion business. But it’s too early and the outlook is too uncertain to pick winners.
Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of -346.67% and -4.91%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
This top marijuana stock reported sales grew at a breakneck pace last quarter, but that may only be the beginning.
After a fantastic Q3 performance, Bruce Linton paints a glowing picture of what's to come for the big marijuana company.
Marijuana stocks and related ETFs caught investors' attention last year, courtesy of its mysterious rally in mid-2018 on Canada's legalization of recreational marijuana in October. Let's take a look at whether the space will be able to maintain its rally in 2019.